why choose us

First received: May 30, 2023

Clinical Trial: Safety Study of GMDTC Injection in Healthy Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cadmium Exposure

Study Type: INTERVENTIONAL


Official Title: Phase I Clinical Study on the Safety, Tolerability and Pharmacokinetic Characteristics of a Single Dose of GMDTC Administered to Healthy Subjects for Injection

Brief Summary: This trial is a randomized, double-blind, single-center, single-dose escalating Phase I clinical trial designed to evaluate the safety, tolerability, and pharmacokinetic characteristics of injectable GMDTC in healthy subjects

Read more